Is ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a Good Investment?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for the period of 9-Day stands at 2.39% while the stochastic %D for the same period stands at 4.78%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s 20-Day Bollinger Band indicates “Sell”.

About Company

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson’s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Previous Day Activity Analysis

On the last trading day, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) opened the session at $29.2 and after going down -1.92% closed at $28.6. The stock lost -0.6 points in the last trade.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s stock fluctuated in the range of $28.55 and $29.88 during the previous active session. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) traded with the volume of 1.81 Million with average volume of 1.47 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 3.95 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.71 and 22.53 respectively.

Currently the Insider Ownership of the shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at 0.1% and the shares outstanding are 124.8 Million.

Important Ratio Analysis

Some important ratios to consider here for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 38.26 and 9.29 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 9.74 and 0 correspondingly.

The Quick Ratio of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at 11 while the Current Ratio depicts the value of 11.1.

Return on Assets ROA of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at -61.9% whereas, Return on Equity ROE and Return of Investment ROI of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stand at -67.7% and -52.9% respectively.

Stock Performance Analysis

The stock performance of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on the basis of 5 day trade show the dip of -20.22% whereas, the monthly performance of the stock shows decrease of -19.44%.

The quarterly performance of the stock remained in red zone with the value of -10.32% while six month performance of the shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) remained bullish with the count of 0.25%.

The yearly and YTD performance of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) remained down at -3.83% and -0.83% respectively.